The environmental allergy panels market is projected to grow from USD 1.1 billion in 2026 to USD 2.5 billion by 2036, at a CAGR of 8.5%. In-vitro IgE panels will dominate with a 60.0% market share, while respiratory allergies will lead the application segment with a 55.0% share.